Sept 19, 2011 - Interventional Cardiology Devices to be Worth $25.5bn by 2021
Interventional Cardiology Devices to be Worth $25.5bn by 2021, Says
LONDON, September 19, 2011 /PRNewswire/ -- A new report by visiongain, a London-based business information provider predicts the global market for interventional cardiology devices to be worth $25.5bn by 2021. The market generated $9.8bn in 2010 according to Interventional Cardiology Devices: World Market Prospects 2011-2021, published in September 2011.
Interventional cardiology is a well established technique that uses a catheter to treat heart defects and is commonly used in the treatment of coronary artery disease. The interventional cardiology market has significant opportunity to expand with the increasing prevalence of coronary artery disease, especially in the emerging economies.
Visiongain's healthcare industry analyst says 'The interventional cardiology market has enjoyed strong growth over the recent years, despite the setback of 2006/07. Growth will be driven by new technology such as, bioabsorbable stents, drug-eluting balloons and optical coherence tomography. Over the course of the next decade, there will be greater demand for interventional cardiology procedures as the number of people suffering with coronary artery disease increases.'
Visiongain's research suggests that the interventional cardiology market will benefit from the growth of healthcare markets in the emerging economies. Increasing wealth in China and India will lead to an increase in lifestyle related disorders such as diabetes and coronary artery disease. At the same time, mature markets such as the US and Japan will also experience growth, albeit slow, restrained by some regulatory and reimbursement issues discussed in detail in the report.
Visiongain analyses the coronary stent, PTCA balloon and intravascular imaging markets, with respect to the market size, leading companies and products, and pipeline developments. Visiongain predicts that this market will grow steadily to 2021, primarily driven by technological innovation and new products reaching the market. This new study adds to visiongain's wide range of analytical reports in healthcare and other industry areas.
To see full sample pages please click on:
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Telecoms, Energy, Pharmaceutical, Defence, Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44(0)207-336-6100
Source: 2011 PR Newswire Europe Limited. All Rights Reserved., All Rights Reserved.